Mycobacterium peregrinum infection in a patient with AIDS

Internal Medicine

Volumn 44, Issue 3, 2005, Pages 266-269

  Sakai, Toshihiko ^a   Kobayashi, Chizuko ^a   Shinohara, Masao ^a  

^a NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

Author keywords

AIDS; Clarithromycin; Faropenem; Imipenem; Mycobacterium fortuitum; Mycobacterium peregrinum

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; C REACTIVE PROTEIN; CEFAZOLIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DNA; ERYTHROMYCIN; FLUCONAZOLE; FROPENEM; IMIPENEM; PENICILLIN G; PIPERACILLIN; VANCOMYCIN;

ABSCESS DRAINAGE; ACID FAST BACTERIUM; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CANDIDA; CASE REPORT; CERVICAL LYMPH NODE; CLINICAL EXAMINATION; CONSULTATION; DNA DNA HYBRIDIZATION; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM PEREGRINUM; PATIENT REFERRAL; PERITONSILLAR ABSCESS; REMISSION; THRUSH; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIV; HUMANS; IMIPENEM; LACTAMS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS, ATYPICAL; RNA, VIRAL;

EID: 17744385761     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.266     Document Type: Article

References (8)

1. Good RC. Opportunistic pathogens in the genus Mycobacterium. Annu Rev Microbiol 39: 347-369, 1985.
2. Tanaka E, Kimoto T, Tsuyuguchi K, Suzuki K, Amitani R. Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection. J Infect Chemother 8: 252-255, 2002.
3. Pagnoux C, Nassif X, Boifard C, Timsit J. Infection of continuous subcutaneous insulin infusion site with Mycobacterium peregrinum. Diabetes Care 21: 191-192, 1998.
4. Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 152: 500-514, 1985.
5. Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 324: 1332-1338, 1991.
6. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Medical section of the American Lung Association (March 1997). Am J Respir Crit Care Med 156: S1-S25, 1997.
7. Wallace RJ Jr, Nash DR, Tsukamura M, Blacklock ZM, Silcox VA. Human disease due to Mycobacterium smegmatis. J Infect Dis 158 52-59, 1988.
8. Dalovisio JR, Pankey GA, Wallace RJ, Jones DB. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 3: 1068-1074, 1981.